Effect of Multiple Dose Levels of SRT2379 on Endotoxin-Induced Inflammation

NCT01416376 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Sepsis

Interventions

DRUG: SRT2379
DRUG: Placebo

Sponsor

Sirtris, a GSK Company

Collaborators

[object Object]